NVP-2203
/ NVP Healthcare
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 11, 2024
To Evaluate the Safety and the Pharmacokinetics of NVP-2203
(clinicaltrials.gov)
- P1 | N=50 | Completed | Sponsor: NVP Healthcare | Not yet recruiting ➔ Completed
Trial completion
October 05, 2023
To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients
(clinicaltrials.gov)
- P3 | N=228 | Recruiting | Sponsor: NVP Healthcare | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular
1 to 2
Of
2
Go to page
1